Boyalife Hong Kong

Boyalife is a diversified biotechnology group with a significant presence in Hong Kong and mainland China, specializing in regenerative medicine and stem cell technologies. The company operates one of the world's largest stem cell banking networks and provides automated cell processing solutions through its subsidiary, ThermoGenesis. Boyalife's research and development efforts focus on cell-based therapies, including CAR-T treatments for cancer and mesenchymal stem cell applications for degenerative diseases. The group is also recognized for its large-scale animal cloning projects and its efforts to establish international standards in cell therapy manufacturing and clinical translation.